GGrantIndex
Sort

51,593 grants matching hepatitis

Quadrivalent Human Papillomavirus (HPV) Vaccine in Cancer Survivors

$551,166
Wendy Landier · University Of Alabama At Birmingham · R01 · FY2015 · CA

dnTGF Beta RII Mice and PBC

$551,093
Merrill E Gershwin · University Of California At Davis · R01 · FY2010 · DK

Hepatic Gene Transfer for Treatment of Hemophilias A & B

$551,004
Mark A Kay · Stanford University · R01 · FY2016 · HL

Immunopathogenesis of non-alcoholic fatty liver disease

$550,978
Senad Divanovic · Cincinnati Childrens Hosp Med Ctr · R01 · FY2019 · DK

The Pathobiology of Hepatic Epithelia

$550,976
Nicholas F. Larusso · Mayo Clinic Rochester · R01 · FY2013 · DK

Gut microbiota mediated bile acid alterations in hepatic carcinogenesis

$550,892
Wei Jia · University Of Hawaii At Manoa · U01 · FY2018 · CA

Building a functional biliary system from hepatocytes

$550,831
Stacey S Huppert · Cincinnati Childrens Hosp Med Ctr · R01 · FY2017 · DK

HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids

$550,788
Pedro Mateu-Gelabert · National Development And Research Institutes, Inc. · R01 · FY2017 · DA

Addressing the Midlife Mortality Crisis: Place-Based Modeling, Trend Analysis and Policy Interventions

$550,758
Myron P. Gutmann · University Of Colorado · R01 · FY2025 · AG

Highly penetrant and immunogenic mouse models of non-viral HCC that are suitable for evaluation of immune checkpoint inhibitors

$550,740
Michael Karin · University Of California, San Diego · R01 · FY2019 · CA

Scaffolds for culture and transplantation of islet organoids

$550,689
Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2020 · DK

Scaffolds for culture and transplantation of islet organoids

$550,689
Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2021 · DK

Scaffolds for culture and transplantation of islet organoids

$550,689
Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2022 · DK

The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial

$550,678
Jason S Haukoos · Denver Health And Hospital Authority · R01 · FY2021 · DA

Population Data and Modeling Core

$550,656
Benjamin P Linas · Weill Medical Coll Of Cornell Univ · P30 · FY2025 · DA

Long term efficacy and safety of orlistat for type 1 hyperlipoproteinemia: a randomized, double-blind, placebo-controlled trial

$550,629
Abhimanyu Garg · Ut Southwestern Medical Center · R61 · FY2023 · HL

In Situ Albumin Binding siRNAs for Triple Negative Breast Cancer Tumor Penetration and Molecularly Targeted Therapy

$550,518
Craig Lewis Duvall · Vanderbilt University · R01 · FY2025 · CA

Kentucky Outreach Service Kiosk (KyOSK): Reducing Overdose, Hepatitis C, and Other Drug-related Risks in Rural Appalachia through Health Kiosks

$550,448
April Marie Young · University Of Kentucky · R01 · FY2025 · DA

Health Literacy Assessment and Intervention to Reduce Disparities: FLIGHT/VIDAS II

$550,446
Raymond L Ownby · Nova Southeastern University · R01 · FY2019 · MD

GENETIC REGULATION OF IGF-I IN PEAK BONE DENSITY OF MICE

$550,401
Clifford J Rosen · Jackson Laboratory · R01 · FY2006 · AR

Insulin Stimulation of Hepatic Fatty Acid Synthesis via SREBP-1 c

$550,384
Michael S Brown · Ut Southwestern Medical Center · P01 · FY2013 · HL

Increasing Hep B screening among Korean church attendees

$550,382
Roshan Bastani · University Of California At Davis · P01 · FY2006 · CA

Alcohol Reduction in Medical Illnesses:HCV as Prototype

$550,367
Case Western Reserve University · R01 · FY2005 · AA

Microfluidic organoid model of cardio-hepatic physiology and disease

$550,365
David Sachs · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · HL

Congenital CMV and CNS Infection Mechanisms of Protective Immunity

$550,305
William J Britt · University Of Alabama At Birmingham · R01 · FY2014 · AI